This study was achieved in a special farm in Basaer village which lies on the right side of the Euphrates in Heet district l Anbar, Heet lies 70 K.M west Ramadi during the pesiod, From 17/4/2018 to 30/5/2018. 28 ewes aged 2-4 years of awassi with average weight 40-50 k.g. and a one lambing. All ewes were diagnosed by using the real-time Ultrasonography to make sure there is no pregnancy among the female before the experiment. All ewes were synchronized with intravaginal sponges impregnated with 60 mg MAP for 12 days before sponges withdrawal and eCG 500 IU (Novormon made in Argentina). The pregnant ewes were divided randomly and equally (7 each group) Into 4 groups The ewes in the first group were received an intramuscular injection of 160 Mµ of arginine 3 times daily. The second group were treated with 2ml/head a combination of selenium plus vitamin E (vitamin E 68mg/ml Selenium 1.5mg/ml). The third group was treated by injection of 160 Mµ of arginine and selenium with vitamin E 2 ml/head. The four groups were injected with normal saline which was considered as a control group. The ewes were inseminated by ram at the end of the hormonal program for five days. The samples of blood were taken from the Jugular vein at four-day treatment Also, In the 4, 10, 15, 18. The results of the experiment showed no significant deferent in WBC, Progesterone estrogen, growth hormone, prolactin, early of pregnancy in the treatment with the control group. The experiment showed a significant difference in the Progesterone concentration within a single treatment in three treatment without control. concluded from this study that use of arginine and selenium with vitamin E improves ewes health, increasing the progesterone to maintain pregnancy.
The study was conducted in one of the fields of the private sector within Basaaer the village of the district of Hit / Anbar at 180 km west of Baghdad, during the period from 17/4/2018 to 30/5/2018. 28 ewes with an age of 2-4 years with a weight of 40-50 kg with at least one birth. All ewes were tested using ultrasonography to ensure that they were free of pregnancy before the start of the experiment. Synchronization of estrus with intravaginal sponges was achieved in ewes, and inseminated with rams at the end of the hormonal program. The rams remained with the females for five days. The ewes were randomly divided into four equal groups (7 ewes in each group). The first group were injected with 160 micro mol / kg body weight and from the fifth day of the inseminated until day 20 of pregnancy The second group was treated by injecting selenium plus vitamin E with (2 ml/head α-Tocopheryl Acetate 68mg/ml Selenium 1.5mg/ml) intramuscular. The first dose was given on day 5 and the second one on day 19 of insemination the early at pregnancy. The third group were injected the arginine with the selenium plus vitamin E emulsion, The fourth group was injected with a physiological saline solution and considered as control group. Blood samples were collected from jugular vein prior to treatment on day 4 of the insemination as well as on days 10, 15, and 18, to measure the changes in the chemical properties at the early of pregnancy. The results of the study showed a significant difference (P≤0.05) between the treatments and control groups. The results showed a decrease in the concentration of urea and ALT enzyme as compared with the first group and control. The present study did not show a significant differences at early of pregnancy in the concentration of cholesterol, total protein, albumin, globulin, glucose, and AST enzyme at the early of pregnancy for ewes. The results also showed a significant difference (P≤0.05) between the different withdrawal periods within the same treatment in the control and other groups the concentration of ALT enzyme, and total protein. It can be concluded from this study that the use of arginine and selenium with vitamin E improves maternal health by reducing the level of urea and ALT enzyme and maintaining pregnancy after insemination.
This study was achieved in one of the fields of special factor in Basaer village Euphrates in Heet district l Anbar,. For the period between 1/2/2014 to 1/7/2014, 40 local female goats aged 2-4 years with a weight ranging from 35-40 kg, and at least one birth, all female goats were examined using an ultrasound machine. Sonar) to make sure they are free of pregnancy before the start of the experiment. Females were randomly divided into two equal groups (20 goats in each group), Female group I (T1) was treated by placing the one-time used cider in the vagina for 12 days. Upon removal eCG 500 IU was injected into the muscle withdrawal, Females of the second group (T2) were treated with the application of the vaginal progesterone (CIDR) device containing 0.3 g progesterone for 12 days removal, withdrawal eCG 500 IU was injected into the muscle. The females were inseminated through the release of males with them at the end of the hormonal program and the male was rotated between the cages to avoid the differences caused by male influence and continued presence of males with females for five days. The results of the study showed the superiority of the new CIDR group over the CIDR group used no significantly in the performance reproductive. The results of the present study showed an increase in the weight of newborns due to the impact of the weight of the mother, and that hormonal treatments used in the standardization of estrus did not affect the weight of births at birth or their vitality. However, the results showed that the births of high-weight mothers led to increased birth weight and increased vitality and preserve their life after birth. We conclude from the present study that the use of CIDR in standardizing estrus gives good results and improves reproductive performance in goats when injecting hormone eCG, can be reused CIDR again and gives acceptable results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.